UA61069C2 - 1(2h) quinolinecarbonic acid derivatives, a method for preparation thereof, a method for preparation of substances with antibiotic properties - Google Patents
1(2h) quinolinecarbonic acid derivatives, a method for preparation thereof, a method for preparation of substances with antibiotic properties Download PDFInfo
- Publication number
- UA61069C2 UA61069C2 UA98095030A UA98095030A UA61069C2 UA 61069 C2 UA61069 C2 UA 61069C2 UA 98095030 A UA98095030 A UA 98095030A UA 98095030 A UA98095030 A UA 98095030A UA 61069 C2 UA61069 C2 UA 61069C2
- Authority
- UA
- Ukraine
- Prior art keywords
- zyl
- formulas
- formula
- compounds
- fact
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 230000003115 biocidal effect Effects 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000000126 substance Substances 0.000 title abstract description 5
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 10
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 7
- -1 cyclic acetal Chemical class 0.000 claims abstract description 7
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011734 sodium Substances 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical group CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 4
- 238000012876 topography Methods 0.000 claims 1
- 101150058891 alc1 gene Proteins 0.000 abstract 1
- 101150117093 alc2 gene Proteins 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- WACQKHWOTAEEFS-UHFFFAOYSA-N cyclohexane;ethyl acetate Chemical compound CCOC(C)=O.C1CCCCC1 WACQKHWOTAEEFS-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000005638 hydrazono group Chemical group 0.000 description 1
- PSXRWZBTVAZNSF-UHFFFAOYSA-N hydron;quinoline;chloride Chemical compound Cl.N1=CC=CC2=CC=CC=C21 PSXRWZBTVAZNSF-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical class C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9602473A FR2745289B1 (fr) | 1996-02-28 | 1996-02-28 | Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques |
PCT/FR1997/000352 WO1997031926A1 (fr) | 1996-02-28 | 1997-02-27 | Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques |
Publications (1)
Publication Number | Publication Date |
---|---|
UA61069C2 true UA61069C2 (en) | 2003-11-17 |
Family
ID=9489660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA98095030A UA61069C2 (en) | 1996-02-28 | 1997-02-27 | 1(2h) quinolinecarbonic acid derivatives, a method for preparation thereof, a method for preparation of substances with antibiotic properties |
Country Status (27)
Country | Link |
---|---|
US (1) | US6002006A (es) |
EP (1) | EP0885232B1 (es) |
JP (1) | JP3856241B2 (es) |
KR (1) | KR19990087323A (es) |
CN (1) | CN1072226C (es) |
AT (1) | ATE231153T1 (es) |
AU (1) | AU708022B2 (es) |
BR (1) | BR9707777A (es) |
CA (1) | CA2247172C (es) |
CZ (2) | CZ294483B6 (es) |
DE (1) | DE69718444T2 (es) |
DK (1) | DK0885232T3 (es) |
EA (1) | EA001157B1 (es) |
ES (1) | ES2186871T3 (es) |
FR (1) | FR2745289B1 (es) |
HU (1) | HUP9900937A3 (es) |
IL (1) | IL125873A (es) |
NO (1) | NO983956L (es) |
NZ (1) | NZ331599A (es) |
OA (1) | OA10846A (es) |
PL (1) | PL185497B1 (es) |
PT (1) | PT885232E (es) |
SK (2) | SK284016B6 (es) |
TR (1) | TR199801708T2 (es) |
UA (1) | UA61069C2 (es) |
WO (1) | WO1997031926A1 (es) |
YU (1) | YU37198A (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3612513A4 (en) * | 2017-04-17 | 2020-09-30 | Ohio State Innovation Foundation | TYPE II TOPOISOMERASE INHIBITORS AND METHOD OF MANUFACTURING AND USING THEREOF |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61221192A (ja) * | 1985-03-27 | 1986-10-01 | Toyo Soda Mfg Co Ltd | ホスホナ−ト誘導体 |
FR2718450B1 (fr) * | 1994-04-08 | 1997-01-10 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
1996
- 1996-02-28 FR FR9602473A patent/FR2745289B1/fr not_active Expired - Fee Related
-
1997
- 1997-02-27 EA EA199800767A patent/EA001157B1/ru not_active IP Right Cessation
- 1997-02-27 US US09/125,537 patent/US6002006A/en not_active Expired - Lifetime
- 1997-02-27 CA CA002247172A patent/CA2247172C/fr not_active Expired - Lifetime
- 1997-02-27 KR KR1019980706732A patent/KR19990087323A/ko not_active Application Discontinuation
- 1997-02-27 IL IL12587397A patent/IL125873A/xx not_active IP Right Cessation
- 1997-02-27 BR BR9707777A patent/BR9707777A/pt not_active Application Discontinuation
- 1997-02-27 WO PCT/FR1997/000352 patent/WO1997031926A1/fr active IP Right Grant
- 1997-02-27 AU AU19299/97A patent/AU708022B2/en not_active Ceased
- 1997-02-27 JP JP53067297A patent/JP3856241B2/ja not_active Expired - Lifetime
- 1997-02-27 CZ CZ2004510A patent/CZ294483B6/cs not_active IP Right Cessation
- 1997-02-27 DE DE69718444T patent/DE69718444T2/de not_active Expired - Lifetime
- 1997-02-27 HU HU9900937A patent/HUP9900937A3/hu unknown
- 1997-02-27 ES ES97907142T patent/ES2186871T3/es not_active Expired - Lifetime
- 1997-02-27 DK DK97907142T patent/DK0885232T3/da active
- 1997-02-27 PT PT97907142T patent/PT885232E/pt unknown
- 1997-02-27 EP EP97907142A patent/EP0885232B1/fr not_active Expired - Lifetime
- 1997-02-27 TR TR1998/01708T patent/TR199801708T2/xx unknown
- 1997-02-27 CZ CZ982545A patent/CZ254598A3/cs unknown
- 1997-02-27 NZ NZ331599A patent/NZ331599A/xx unknown
- 1997-02-27 AT AT97907142T patent/ATE231153T1/de not_active IP Right Cessation
- 1997-02-27 UA UA98095030A patent/UA61069C2/uk unknown
- 1997-02-27 CN CN97192624A patent/CN1072226C/zh not_active Expired - Fee Related
- 1997-02-27 PL PL97328601A patent/PL185497B1/pl not_active IP Right Cessation
- 1997-02-27 SK SK124-2002A patent/SK284016B6/sk unknown
- 1997-02-27 SK SK1122-98A patent/SK283620B6/sk unknown
-
1998
- 1998-08-27 NO NO983956A patent/NO983956L/no not_active Application Discontinuation
- 1998-08-28 OA OA9800151A patent/OA10846A/fr unknown
- 1998-08-28 YU YU37198A patent/YU37198A/sh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850000889B1 (ko) | 삼-치환 이미다졸 유도체의 제조방법 | |
JPH0768216B2 (ja) | 置換されたピリジン−2,3−ジカルボキシレ−トエステル類の製造法 | |
JPH0751562B2 (ja) | 4−置換1,4−ジヒドロピリジン類の新規製法 | |
RU98117621A (ru) | Новые производные пиперазина и пиперидина, способ их получения, фармкомпозиция на их основе, способ лечения, промежуточный продукт | |
HU187816B (en) | Process for producing cepheme-carboxylic acid derivatives | |
CZ216593A3 (en) | Process for preparing amlodipinebenzenesulfonate | |
UA61069C2 (en) | 1(2h) quinolinecarbonic acid derivatives, a method for preparation thereof, a method for preparation of substances with antibiotic properties | |
US5142054A (en) | Optically pure 1,3-dioxenones, methods for preparing same and use thereof | |
US4769462A (en) | Novel 2-carbamoylnicotinic and 3-quinolinecarboxylic acids and esters | |
EP0063359B1 (en) | 1,4-dihydropyridine derivatives and processes for preparing the same | |
Mock et al. | Resolution of diastereomeric sulfoximines | |
RU2228929C2 (ru) | Способ получения 3s-3-амино-3-пиридилпропионовой кислоты и ее производных и промежуточное вещество | |
US5250694A (en) | Process for the preparation of 2,3-pyridine-dicarboxylic acids from 3-(2-imidazolin-2-yl)picolinic acids | |
KR930001404B1 (ko) | 디아릴 화합물의 제조방법 | |
CA1137482A (en) | Process for the production of 5-aminoisoxazoles | |
Keuper et al. | Synthesis and Characterization of Novel Pyridines and 3, 3′‐Bridged Bipyridines Using 1, x‐Cyclohexanediones | |
Asiri | Synthesis of 2, 3-di-(2-adamantylidene) succinic anhydride: a highly non-photochromic overcrowded fulgide | |
EP0140327B1 (en) | Bis-dioxopiperazine derivatives, process for their preparation, antitumor agents comprising them and compositions containing them | |
EP0118120B1 (en) | 1,4-dihydropyridine compound | |
HU194176B (en) | Process for production of derivatives of new 7-phormildekahydridinoline | |
FI75342C (fi) | Ett nytt foerfarande foer framstaellning av piroxicam och mellanprodukter laempliga foer dess framstaellning. | |
US5106987A (en) | Process for preparation of fluoromethyl-substituted pyridine dicarboxylates | |
CA2038513C (en) | Process for preparation of fluoromethyl-substituted pyridine dicarboxylates | |
US4921961A (en) | 2-Carbamoyl-3-quinolinecarboxylic acids and salts as intermediates for the preparation of herbicidal 2-(5-isoproyl-5-methyl-4-oxo-2-imidazolin-2-yl)-3-quinolinecarboxylic acids | |
JPH0219117B2 (es) |